Day: December 15, 2021

NuveiPayment Technology PartnerMONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) (Nasdaq: NVEI) (TSX: NVEI), through its Simplex platform, one of the largest fiat infrastructure solutions for digital currencies globally, has partnered with Project Ark, a blockchain-powered platform that supports animal and environmental conservation projects by creating and selling NFT collectibles. This partnership will enable consumers to purchase NFTs directly with fiat currencies without the need to leave the dedicated NFT platform. The purchase of Project Ark’s digital collectibles, ImpactNFTs, aims to ensure transparent donations to associations and NGOs supporting environmental protections and carbon offsetting, creating a blockchain-based decentralized autonomous organization (DAO)...

Lerøy Seafood Group ASA (“LSG”) announced on 29 June 2021 that Scottish Sea Farms Ltd., a vertically integrated Scottish salmon farming company owned 50/50 by LSG and SalMar ASA, had signed a Share Purchase Agreement to acquire 100% of the shares in Grieg Seafood Hjaltland UK Ltd. from Grieg Seafood ASA (the “Transaction”). Completion of the Transaction was subject to certain customary closing conditions, including the approval from relevant competition authorities. Completion of the Transaction took place today in accordance with the transaction agreement. For queries, please contact: Sjur S. Malm, CFO Lerøy Seafood Group, +47 41 77 20 20 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. About Lerøy Seafood Group ASA Lerøy Seafood Group...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE 15 December 2021 Stagecoach Group plc – Rule 2.9 Announcement In accordance with Rule 2.9 of the UK City Code on Takeovers and Mergers (the “Code“), Stagecoach Group plc (“Stagecoach“) confirms that, as at the date of this announcement, it has in issue 551,220,666 ordinary shares of 125/228th pence each. The International Securities Identification Number for the ordinary shares of Stagecoach is GB00B6YTLS95. Enquiries Mike Vaux, Company Secretary                                +44 (0) 1738 442111         Disclosure requirements of the Code Under Rule 8.3(a) of the Code, any person...

Reference is made to (i) the stock exchange announcement from Grieg Seafood ASA (the “Company”) released on 29 June 2021 regarding the entering into a Share Purchase Agreement with Scottish Sea Farms Ltd regarding the sale of all shares in its wholly owned subsidiary Grieg Seafood Hjaltland Ltd, the parent company of the Company’s Shetland business (the “Transaction”) as well as (ii) the stock exchange announcement released on 8 December 2021 regarding the clearance of the Transaction by relevant competition authorities. The Company is pleased to announce that the Transaction has been successfully completed on 15 December 2021. Going forward, the Company will narrow focus, resources and investments to Norway and Canada, which are the farming regions with the largest potential for sustainable growth. The sale...

SalMar ASA announced on 29 June 2021 that Scottish Sea Farms Ltd., a vertically integrated Scottish salmon farming company owned 50/50 by Lerøy Seafood Group ASA and SalMar ASA, had signed a Share Purchase Agreement to acquire 100% of the shares in Grieg Seafood Hjaltland UK Ltd. from Grieg Seafood ASA (the “Transaction”). Completion of the Transaction was subject to certain customary closing conditions, including the approval from relevant competition authorities. Completion of the Transaction took place today in accordance with the transaction agreement. For queries, please contact: Leif Inge Nordhammer, Board Chair SalMar ASA, +47 916 85 250 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

IZEA honored for best work-life balance, outstanding leadership Orlando, Florida, Dec. 15, 2021 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, data, and services for the world’s leading brands, announced today that it has won two Comparably.com awards for company culture excellence. IZEA ranked in the Top 50 of Comparably’s 2021 Best Company Work-Life Balance list for small to midsize companies and CEO Ted Murphy has been recognized as one of Comparably’s Best CEOs of 2021. Murphy founded IZEA in 2006 and is considered the father of modern influencer marketing. He launched the first marketplace that paid influencers to create content on behalf of brands and was instrumental in developing the frameworks for sponsored content, including the use of disclosure policies...

SATO Corporation, Stock Exchange Release, 15 December 2021 at 5:00 pm The credit rating agency Standard & Poor’s has revised SATO Corporation’s rating outlook from negative to stable. Further information: CFO Markku Honkasalo, tel. +358 201 34 4226www.sato.fi DISTRIBUTION: NASDAQ Helsinki Ltd, Euronext Dublin, main media, www.sato.fi SATO is one of Finland’s leading rental housing providers. SATO aims to offer a comprehensive choice of rental housing and an excellent customer experience. At year-end 2020, SATO owned close to 26,800 apartments in Finland’s largest growth centres and in St. Petersburg. We promote sustainable development and initiative through our operations and work in open interaction with our stakeholders to generate added value. We operate profitably and with a long-term view. We increase the...

Lund, December 15, 2021 – Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that preclinical data on its candidate drug tasquinimod, a small molecule immunomodulator, are now available on the company’s website. The data were presented at two poster presentations at the 63rd ASH Annual Meeting & Exposition in Atlanta, Georgia. The results presented are part of Active Biotech’s program to address the unmet medical needs to treat hematological malignances, including multiple myeloma. Currently, a phase Ib/IIa trial with tasquinimod in patients with multiple myeloma is ongoing. “These presentations are an integral part of our clinical program around tasquinimod. The first poster is from our collaboration with an academic group at Vrije Universiteit, Brussel, to further study tasquinimod in the preclinical setting of multiple...